Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03425292
Title A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors John Wayne Cancer Institute
Indications

glioblastoma

Therapies

Temozolomide

Ipilimumab + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.